Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Hypertension. 2022 Nov 30;80(2):416–425. doi: 10.1161/HYPERTENSIONAHA.122.20280

Figure 3: Pharmacological inhibition of Panx1 inhibits sympathetic nerve induced vasoconstriction.

Figure 3:

(A-C) EFS-induced vasoconstriction with or without probenecid (2 mM) (D-F) EFS-induced vasoconstriction with or without spironolactone (20 μM). Data were analyzed by repeated measures two-way ANOVA and Sidak post hoc test. *p<0.05, **p<0.01, ***p<0.001, **** p<0.0001